Julianna LeMieux

1 week ago | genengnews.com | Julianna LeMieux

Home Topics Drug Discovery Several ALS Patients See Remarkable Response to ASO Treatment Credit: Kateryna Kon/Science Photo Library/Getty Images Credit: Kateryna Kon/Science Photo Library/Getty Images Typically, the goal of ALS treatments is to slow the disease or halt progression. But new data from the antisense oligonucleotide (ASO) jacifusen for FUS-ALS show that two patients went beyond the expected, and showed improvements.

2 weeks ago | genengnews.com | Julianna LeMieux

Home News Blood Aging Revealed Through a Novel Epigenetic Clonal Tracing Method Red blood cells in travel an artery Credit: Thinkhubstudio / 1005715630 / iStock / Getty Images Plus The blood system changes over time: a subset of stem cells outcompete their neighbors and gradually take over blood production. In addition, the blood stem cell reservoir shrinks and becomes dominated by clones that show a preference for producing myeloid cells, immune cells linked to chronic inflammation.

2 weeks ago | genengnews.com | Julianna LeMieux |Kevin Davies

Home Topics Genome Editing The News from New Orleans: GEN‘s Takeaways from ASGCT New Orleans [ANDREY DENISYUK / 2182079672/ Moment] New Orleans [ANDREY DENISYUK / 2182079672 / Moment] Kevin Davies, PhD, editorial director and Julianna LeMieux, PhD, deputy editor in chief at GEN have been on the ground of the ASGCT meeting for a few days—in the talks, expo hall, and press room, covering as much of the news as they can.

2 weeks ago | genengnews.com | Julianna LeMieux |Alex Philippidis

Home Topics OMICs 10x Settles Bruker, Vizgen Patent Lawsuits Credit: 129310646 / Tetra images / Getty Images Credit: 129310646 / Tetra images / Getty Images 10x Genomics has settled patent infringement lawsuits with a pair of rivals, Bruker and Vizgen, through settlements that could reshape competition within the emerging single-cell and spatial genomics fields.

3 weeks ago | genengnews.com | Julianna LeMieux

Home Insights Proteomic Technology From Nomic Flows to 1,000 Plex An antibody pair pre-assembled onto its own bead is the core of Nomic's proteomics technology [Nomic Bio] An antibody pair pre-assembled onto its own bead is the core of Nomic's proteomics technology [Nomic Bio] Even the most die-hard genomics aficionados can admit that proteomics is having a moment: researchers are asking more protein-based questions to uncover new biology.